Related Experiment Video
Updated: Aug 8, 2026

Immuno-fluorescence Assay of Leptospiral Surface-exposed Proteins
Published on: July 1, 2011
Immunoreactivity and bioactivity of lipopolysaccharide-binding protein in normal and heat-inactivated sera
K Mészáros1, S Aberle, M White
1Department of Sepsis Research, XOMA Corporation, Berkeley, California 94710.
Insights
Serum
Area of Science:
- Immunology
- Biochemistry
Background:
- Lipopolysaccharide (LPS) potentiation by serum relies on LPS-binding protein (LBP) facilitating LPS-CD14 receptor interaction.
- LPS-binding protein (LBP) is crucial for immune responses to Gram-negative bacteria.
Purpose of the Study:
- To investigate the heat sensitivity of LBP and serum bioactivity.
- To assess the impact of heat inactivation on LPS potentiation by serum.
Main Methods:
- Enzyme-linked immunosorbent assay (ELISA) to measure immunoreactivity.
- Assay for bioactivity by measuring LPS induction of tumor necrosis factor (TNF) in monocytes.
- Comparison of human and fetal bovine sera heat sensitivity.
Main Results:
- Recombinant LBP and various sera exhibited significant heat sensitivity in both immunoreactivity and bioactivity.
- Human sera demonstrated higher activity and heat sensitivity compared to fetal bovine sera.
- Standard heat inactivation (56°C, 30 min) of human serum caused a 70% reduction in bioactivity, leading to an apparent decrease in LPS potency.
Conclusions:
- Standard heat inactivation procedures significantly diminish the bioactivity of serum components involved in LPS potentiation.
- The heat sensitivity of LBP and serum bioactivity has critical implications for experimental procedures and interpretation of results involving LPS.
- Researchers should consider the impact of heat inactivation on serum components when designing experiments involving LPS and immune cell activation.
Abstract:
The lipopolysaccharide (LPS)-potentiating effect of serum is due to LPS-binding protein (LBP), which facilitates the binding of LPS to CD14 receptors. We observed a remarkable heat sensitivity of recombinant LBP and various sera with respect to both immunoreactivity (measured by enzyme-linked immunosorbent assay) and bioactivity (potentiation of LPS induction of tumor necrosis factor in monocytes). Human sera were more active and more heat sensitive than fetal bovine sera. The commonly practiced heat inactivation of human serum (56 degrees C, 30 min) resulted in a 70% loss of bioactivity, which caused an apparent decrease in the potency of LPS.
More Related Videos
11:10Antibody Binding Specificity for Kappa (Vκ) Light Chain-containing Human (IgM) Antibodies: Polysialic Acid (PSA) Attached to NCAM as a Case Study
Published on: June 29, 2016
08:47Opsonophagocytic Killing Assay to Assess Immunological Responses Against Bacterial Pathogens
Published on: April 5, 2019